GPT Healthcare Ltd

GPT Healthcare maintains a conservative capital structure with a debt-to-equity ratio of 0.14, indicating limited leverage and a strong equity base. The company's liquidity position is moderate, as reflected in a current ratio of 1.06, suggesting it can meet short-term obligations but with limited buffer. Free cash flow of INR 190.26 million indicates positive cash generation, though capital expenditures of INR 499.26 million suggest ongoing investment in infrastructure. Profitability metrics show a return on equity (ROE) of 20.14% and a return on assets (ROA) of 12.99%, both exceeding the industry median for Healthcare Facilities & Services. These figures suggest efficient use of equity and assets to generate returns. Gross profit of INR 3.28 billion and operating income of INR 663.25 million indicate strong cost control and operational efficiency. The company's revenue is concentrated in four hospitals located in Kolkata, Agartala, and Howrah, with no disclosed geographic diversification beyond West Bengal. This concentration may expose the company to regional economic or regulatory risks. No material segment disclosures are available, but the primary revenue driver is hospital services, with a secondary contribution from the nursing institute in Agartala. GPT Healthcare reported revenue of INR 4.07 billion in the latest period, with no disclosed year-over-year growth rate. Analysts have assigned a mean price target of INR 136.00, with a single "buy" recommendation and no "strong buy" or "hold" ratings. The company's outlook for the current fiscal year is neutral, with no significant revenue growth expected in the near term. The risk assessment highlights a medium liquidity risk due to a current ratio of 1.06 and a negative net cash position after subtracting total debt. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. However, the company's capital expenditures may require additional financing, which could increase leverage. Recent filings and transcripts do not indicate material events or strategic shifts. The company continues to focus on hospital operations and capacity expansion, with no disclosed M&A activity or major regulatory changes affecting its operations.